SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.55-2.0%12:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (16517)12/7/2003 4:17:15 PM
From: Robert K.   of 17367
 
btw> on exhibit 7 look at the total capacity of bgen/idec.
IMO that makes them a force and a company worth getting at the right price. DNA is right there also.
As for xoma , about 1% of world capacity is IMO impressive.
Thats what makes xoma a player in the collaborate-in game.
Then of course is the expression & phage & humanization assets. I am just about the only one on net that seems to see the potential here. I am tellin you IMO, this is gonna be big plus for company going forward. Xoma is picking their deals and taking only the best opportunies. u will see. Xoma is a r&D force. skd
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext